University of Washington-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2024

  1. An Early Treatment With BKI-1748 Exhibits Full Protection Against Abortion and Congenital Infection in Sheep Experimentally Infected With Toxoplasma gondii

    Journal of Infectious Diseases, Vol. 229, Núm. 2, pp. 558-566

2021

  1. Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivo

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 17, pp. 92-106

  2. In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 16, pp. 90-101

  3. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases

    Veterinary Parasitology, Vol. 289

2020

  1. Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned

    International Journal for Parasitology, Vol. 50, Núm. 5, pp. 413-422

  2. Neospora caninum: Differential proteome of multinucleated complexes induced by the bumped kinase inhibitor BKI-1294

    Microorganisms, Vol. 8, Núm. 6

  3. Neospora caninum: Structure and fate of multinucleated complexes induced by the bumped kinase inhibitor bki-1294

    Pathogens, Vol. 9, Núm. 5

  4. The Impact of BKI-1294 Therapy in Mice Infected With the Apicomplexan Parasite Neospora caninum and Re-infected During Pregnancy

    Frontiers in Veterinary Science, Vol. 7

2019

  1. Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 7

2018

  1. Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 8, Núm. 1, pp. 112-124

2017

  1. Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2334-2341

  2. In vitro efficacy of bumped kinase inhibitors against Besnoitia besnoiti tachyzoites

    International Journal for Parasitology, Vol. 47, Núm. 12, pp. 811-821

  3. Two novel calcium-dependent protein kinase 1 inhibitors interfere with vertical transmission in mice infected with Neospora caninum tachyzoites

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

2015

  1. In vitro and in vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 10, pp. 6361-6374